Deficient α-synuclein clearance mechanisms in GBA1 mutants leading to intensified α-synuclein accumulation in cortical areas is considered to exacerbate cognitive impairment and, in the long run, induce dementia in GBA1-PD patients [94]. This evidence concerns the gene GBA1 and Parkinson disease.